227 related articles for article (PubMed ID: 1851032)
1. Opportunistic infections in children following renal transplantation.
Harmon WE
Pediatr Nephrol; 1991 Jan; 5(1):118-25. PubMed ID: 1851032
[TBL] [Abstract][Full Text] [Related]
2. [Incidence, prevention and therapy of cytomegalovirus and pneumocystis carinii infection after heart transplantation].
Vetter H; Reichenspurner H; Uberfuhr P; Netz H; Reichart B
Med Klin (Munich); 1992 Oct; 87 Suppl 1():56-9. PubMed ID: 1334222
[TBL] [Abstract][Full Text] [Related]
3. Rejection treatment and cytomegalovirus infection as risk factors for Pneumocystis carinii pneumonia in renal transplant recipients.
Arend SM; Westendorp RG; Kroon FP; van't Wout JW; Vandenbroucke JP; van Es LA; van der Woude FJ
Clin Infect Dis; 1996 Jun; 22(6):920-5. PubMed ID: 8783687
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of prophylactic oral ganciclovir and valacyclovir in high-risk kidney transplant recipients.
Yango A; Morrissey P; Zanabli A; Beaulieu J; Shemin D; Dworkin L; Monaco A; Gohh R
Nephrol Dial Transplant; 2003 Apr; 18(4):809-13. PubMed ID: 12637653
[TBL] [Abstract][Full Text] [Related]
5. Prevention of cytomegalovirus infection in the pediatric renal transplant recipient.
Hibberd PL; Rubin RH
Pediatr Nephrol; 1991 Jan; 5(1):112-7. PubMed ID: 1851031
[TBL] [Abstract][Full Text] [Related]
6. [Cytomegalovirus infection after solid-organ transplantation, its risk factors, direct and indirect effects and prevention strategies].
Varga M; Remport A; Czebe K; Péter A; Toronyi E; Sárváry E; Fehérvári I; Sulyok B; Járay J
Orv Hetil; 2008 Mar; 149(12):551-8. PubMed ID: 18343771
[TBL] [Abstract][Full Text] [Related]
7. Post-transplantation Infections in Bolivia.
Arze S; Arze L; Abecia C
Transplant Proc; 2016 Mar; 48(2):646-53. PubMed ID: 27110022
[TBL] [Abstract][Full Text] [Related]
8. Costs and consequences of cytomegalovirus disease.
Schnitzler MA
Am J Health Syst Pharm; 2003 Dec; 60(23 Suppl 8):S5-8. PubMed ID: 14686228
[TBL] [Abstract][Full Text] [Related]
9. Pneumocystis jirovecii pneumonia 13 years post renal transplant following a recurrent cytomegalovirus infection.
Muhammad Iqbal AH; Lim SK; Ng KP; Tan LP; Chong YB; Keng TC
Transpl Infect Dis; 2012 Aug; 14(4):E23-6. PubMed ID: 22551151
[TBL] [Abstract][Full Text] [Related]
10. The prevention of cytomegalovirus disease in renal transplantation.
Davis CL
Am J Kidney Dis; 1990 Sep; 16(3):175-88. PubMed ID: 1698020
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Low- Versus High-dose Valganciclovir for Prevention of Cytomegalovirus Disease in High-risk Renal Transplant Recipients.
Gabardi S; Asipenko N; Fleming J; Lor K; McDevitt-Potter L; Mohammed A; Rogers C; Tichy EM; Weng R; Lee RA
Transplantation; 2015 Jul; 99(7):1499-505. PubMed ID: 25643140
[TBL] [Abstract][Full Text] [Related]
12. Impact of cytomegalovirus infection on organ transplant recipients.
Rubin RH
Rev Infect Dis; 1990; 12 Suppl 7():S754-66. PubMed ID: 2173105
[TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus infections in renal, heart, heart-lung and liver transplantation.
Pollard RB
Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S97-102. PubMed ID: 2456512
[TBL] [Abstract][Full Text] [Related]
14. Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients.
Dykewicz CA; ; ;
Clin Infect Dis; 2001 Jul; 33(2):139-44. PubMed ID: 11418871
[TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus immune globulin prophylaxis in liver transplantation. A randomized, double-blind, placebo-controlled trial.
Snydman DR; Werner BG; Dougherty NN; Griffith J; Rubin RH; Dienstag JL; Rohrer RH; Freeman R; Jenkins R; Lewis WD; Hammer S; O'Rourke E; Grady GF; Fawaz K; Kaplan MM; Hoffman MA; Katz AT; Doran M;
Ann Intern Med; 1993 Nov; 119(10):984-91. PubMed ID: 8214995
[TBL] [Abstract][Full Text] [Related]
16. Reduction by combination prophylactic therapy with CMV hyperimmune globulin and acyclovir of the risk of primary CMV disease in renal transplant recipients.
Nicol DL; MacDonald AS; Belitsky P; Lee S; Cohen AD; Bitter-Suermann H; Lowen J; Whalen A
Transplantation; 1993 Apr; 55(4):841-6. PubMed ID: 8386404
[TBL] [Abstract][Full Text] [Related]
17. [Pneumocystis carinii pneumonia in renal transplant recipients treated with cyclosporin].
Kim CJ; Pak K; Wakabayashi Y; Ishida A; Arai Y; Konishi T; Kounami T; Tomoyoshi T; Sako H; Okino K
Hinyokika Kiyo; 1989 Apr; 35(4):653-9. PubMed ID: 2544088
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus infection and posttransplant lymphoproliferative disease in renal transplant recipients: results of the U.S. multicenter FK506 Kidney Transplant Study Group.
Pirsch JD
Transplantation; 1999 Oct; 68(8):1203-5. PubMed ID: 10551653
[TBL] [Abstract][Full Text] [Related]
19. Trimethoprim-sulfamethoxazole compared with ciprofloxacin for the prevention of urinary tract infection in renal transplant recipients. A double-blind, randomized controlled trial.
Hibberd PL; Tolkoff-Rubin NE; Doran M; Delvecchio A; Cosimi AB; Delmonico FL; Auchincloss H; Rubin RH
Online J Curr Clin Trials; 1992 Aug; Doc No 15():[4083 words; 46 paragraphs]. PubMed ID: 1343609
[TBL] [Abstract][Full Text] [Related]
20. [Pentamidine inhalation in prevention of pneumocystis carinii pneumonia in treatment of rejection with monoclonal antibody Orthoclone (OKT-3)].
Barenbrock M; Spieker C; Buchholz B; Zidek W; Rahn KH
Med Klin (Munich); 1992 Oct; 87 Suppl 1():53-5. PubMed ID: 1461229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
